Cefuroxime Sodium

Impetigo, Maxillary Sinusitis, Bacterial Meningitis + 17 more

Treatment

1 FDA approval

20 Active Studies for Cefuroxime Sodium

Treatment for

Impetigo

What is Cefuroxime Sodium

CefuroximeThe Generic name of this drug

Treatment SummaryCefepime is a type of antibiotic used to treat infections caused by both gram-positive and gram-negative bacteria. It is particularly effective for infections caused by gonorrhea and certain strains of haemophilus. Cefepime is also resistant to the enzyme beta-lactamase, which some bacteria use to defend against antibiotics.

Zinacefis the brand name

image of different drug pills on a surface

Cefuroxime Sodium Overview & Background

Brand Name

Generic Name

First FDA Approval

How many FDA approvals?

Zinacef

Cefuroxime

1989

163

Approved as Treatment by the FDA

Cefuroxime, commonly known as Zinacef, is approved by the FDA for 1 uses such as Urinary Tract Infection (UTI) .

Urinary Tract Infection (UTI)

Effectiveness

How Cefuroxime Sodium Affects PatientsCefuroxime is an antibiotic that belongs to the cephalosporin family. It works by blocking bacteria from producing proteins that are essential for them to survive and reproduce, which kills the bacteria and stops the infection. Cefuroxime is effective against a variety of bacteria, including Staphylococcus aureus, Streptococcus pneumoniae, Escherichia coli, Haemophilus influenzae, Klebsiella pneumoniae, Moraxella catarrhalis, Neisseria gonorrhoeae, and Borrelia burgdorferi. The drug form of

How Cefuroxime Sodium works in the bodyCefuroxime is a type of antibiotic that works by binding to proteins located inside bacterial cells. Doing so blocks the synthesis of the cell wall, causing the bacteria to burst. It also likely interferes with an inhibitor that keeps the bacteria from self-destructing.

When to interrupt dosage

The advocated measure of Cefuroxime Sodium is contingent upon the determined issue, including Gonorrhea, Urinary Tract Infection (UTI) and Bone and Joint Infections. The amount of dosage fluctuates, as per the technique of administration (e.g. Intravenous or Tablet, film coated) noted in the table beneath.

Condition

Dosage

Administration

mild Streptococcal pharyngitis

, 1500.0 mg, 750.0 mg, 7500.0 mg, 750.0 mg/mL, 90.0 mg/mL, 500.0 mg, 250.0 mg, 150.0 mg/mL, 7.5 mg/mL, 15.0 mg/mL, 250.0 mg/mL, 125.0 mg, 125.0 mg/mL, 75000.0 mg, 225000.0 mg, 95.0 mg/mL, 75.0 mg/mL

, Intravenous, Injection, powder, for solution - Intravenous, Injection, powder, for solution, Intramuscular; Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet - Oral, Tablet, Injection, solution, Injection, solution - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Suspension - Oral, Suspension, Powder, for solution, Powder, for solution - Oral, Powder, for solution - Intravenous, Powder, for solution - Intramuscular; Intravenous, Powder, Powder - Oral, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Granule, for suspension - Oral, Granule, for suspension

moderate Streptococcal tonsillitis

, 1500.0 mg, 750.0 mg, 7500.0 mg, 750.0 mg/mL, 90.0 mg/mL, 500.0 mg, 250.0 mg, 150.0 mg/mL, 7.5 mg/mL, 15.0 mg/mL, 250.0 mg/mL, 125.0 mg, 125.0 mg/mL, 75000.0 mg, 225000.0 mg, 95.0 mg/mL, 75.0 mg/mL

, Intravenous, Injection, powder, for solution - Intravenous, Injection, powder, for solution, Intramuscular; Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet - Oral, Tablet, Injection, solution, Injection, solution - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Suspension - Oral, Suspension, Powder, for solution, Powder, for solution - Oral, Powder, for solution - Intravenous, Powder, for solution - Intramuscular; Intravenous, Powder, Powder - Oral, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Granule, for suspension - Oral, Granule, for suspension

Urinary Tract Infection

, 1500.0 mg, 750.0 mg, 7500.0 mg, 750.0 mg/mL, 90.0 mg/mL, 500.0 mg, 250.0 mg, 150.0 mg/mL, 7.5 mg/mL, 15.0 mg/mL, 250.0 mg/mL, 125.0 mg, 125.0 mg/mL, 75000.0 mg, 225000.0 mg, 95.0 mg/mL, 75.0 mg/mL

, Intravenous, Injection, powder, for solution - Intravenous, Injection, powder, for solution, Intramuscular; Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet - Oral, Tablet, Injection, solution, Injection, solution - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Suspension - Oral, Suspension, Powder, for solution, Powder, for solution - Oral, Powder, for solution - Intravenous, Powder, for solution - Intramuscular; Intravenous, Powder, Powder - Oral, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Granule, for suspension - Oral, Granule, for suspension

Impetigo

, 1500.0 mg, 750.0 mg, 7500.0 mg, 750.0 mg/mL, 90.0 mg/mL, 500.0 mg, 250.0 mg, 150.0 mg/mL, 7.5 mg/mL, 15.0 mg/mL, 250.0 mg/mL, 125.0 mg, 125.0 mg/mL, 75000.0 mg, 225000.0 mg, 95.0 mg/mL, 75.0 mg/mL

, Intravenous, Injection, powder, for solution - Intravenous, Injection, powder, for solution, Intramuscular; Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet - Oral, Tablet, Injection, solution, Injection, solution - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Suspension - Oral, Suspension, Powder, for solution, Powder, for solution - Oral, Powder, for solution - Intravenous, Powder, for solution - Intramuscular; Intravenous, Powder, Powder - Oral, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Granule, for suspension - Oral, Granule, for suspension

Tonsillitis

, 1500.0 mg, 750.0 mg, 7500.0 mg, 750.0 mg/mL, 90.0 mg/mL, 500.0 mg, 250.0 mg, 150.0 mg/mL, 7.5 mg/mL, 15.0 mg/mL, 250.0 mg/mL, 125.0 mg, 125.0 mg/mL, 75000.0 mg, 225000.0 mg, 95.0 mg/mL, 75.0 mg/mL

, Intravenous, Injection, powder, for solution - Intravenous, Injection, powder, for solution, Intramuscular; Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet - Oral, Tablet, Injection, solution, Injection, solution - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Suspension - Oral, Suspension, Powder, for solution, Powder, for solution - Oral, Powder, for solution - Intravenous, Powder, for solution - Intramuscular; Intravenous, Powder, Powder - Oral, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Granule, for suspension - Oral, Granule, for suspension

Lyme Disease

, 1500.0 mg, 750.0 mg, 7500.0 mg, 750.0 mg/mL, 90.0 mg/mL, 500.0 mg, 250.0 mg, 150.0 mg/mL, 7.5 mg/mL, 15.0 mg/mL, 250.0 mg/mL, 125.0 mg, 125.0 mg/mL, 75000.0 mg, 225000.0 mg, 95.0 mg/mL, 75.0 mg/mL

, Intravenous, Injection, powder, for solution - Intravenous, Injection, powder, for solution, Intramuscular; Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet - Oral, Tablet, Injection, solution, Injection, solution - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Suspension - Oral, Suspension, Powder, for solution, Powder, for solution - Oral, Powder, for solution - Intravenous, Powder, for solution - Intramuscular; Intravenous, Powder, Powder - Oral, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Granule, for suspension - Oral, Granule, for suspension

Lower Respiratory Tract Infection (LRTI)

, 1500.0 mg, 750.0 mg, 7500.0 mg, 750.0 mg/mL, 90.0 mg/mL, 500.0 mg, 250.0 mg, 150.0 mg/mL, 7.5 mg/mL, 15.0 mg/mL, 250.0 mg/mL, 125.0 mg, 125.0 mg/mL, 75000.0 mg, 225000.0 mg, 95.0 mg/mL, 75.0 mg/mL

, Intravenous, Injection, powder, for solution - Intravenous, Injection, powder, for solution, Intramuscular; Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet - Oral, Tablet, Injection, solution, Injection, solution - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Suspension - Oral, Suspension, Powder, for solution, Powder, for solution - Oral, Powder, for solution - Intravenous, Powder, for solution - Intramuscular; Intravenous, Powder, Powder - Oral, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Granule, for suspension - Oral, Granule, for suspension

Bacterial Meningitis

, 1500.0 mg, 750.0 mg, 7500.0 mg, 750.0 mg/mL, 90.0 mg/mL, 500.0 mg, 250.0 mg, 150.0 mg/mL, 7.5 mg/mL, 15.0 mg/mL, 250.0 mg/mL, 125.0 mg, 125.0 mg/mL, 75000.0 mg, 225000.0 mg, 95.0 mg/mL, 75.0 mg/mL

, Intravenous, Injection, powder, for solution - Intravenous, Injection, powder, for solution, Intramuscular; Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet - Oral, Tablet, Injection, solution, Injection, solution - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Suspension - Oral, Suspension, Powder, for solution, Powder, for solution - Oral, Powder, for solution - Intravenous, Powder, for solution - Intramuscular; Intravenous, Powder, Powder - Oral, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Granule, for suspension - Oral, Granule, for suspension

moderate Streptococcal pharyngitis

, 1500.0 mg, 750.0 mg, 7500.0 mg, 750.0 mg/mL, 90.0 mg/mL, 500.0 mg, 250.0 mg, 150.0 mg/mL, 7.5 mg/mL, 15.0 mg/mL, 250.0 mg/mL, 125.0 mg, 125.0 mg/mL, 75000.0 mg, 225000.0 mg, 95.0 mg/mL, 75.0 mg/mL

, Intravenous, Injection, powder, for solution - Intravenous, Injection, powder, for solution, Intramuscular; Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet - Oral, Tablet, Injection, solution, Injection, solution - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Suspension - Oral, Suspension, Powder, for solution, Powder, for solution - Oral, Powder, for solution - Intravenous, Powder, for solution - Intramuscular; Intravenous, Powder, Powder - Oral, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Granule, for suspension - Oral, Granule, for suspension

Otitis Media

, 1500.0 mg, 750.0 mg, 7500.0 mg, 750.0 mg/mL, 90.0 mg/mL, 500.0 mg, 250.0 mg, 150.0 mg/mL, 7.5 mg/mL, 15.0 mg/mL, 250.0 mg/mL, 125.0 mg, 125.0 mg/mL, 75000.0 mg, 225000.0 mg, 95.0 mg/mL, 75.0 mg/mL

, Intravenous, Injection, powder, for solution - Intravenous, Injection, powder, for solution, Intramuscular; Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet - Oral, Tablet, Injection, solution, Injection, solution - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Suspension - Oral, Suspension, Powder, for solution, Powder, for solution - Oral, Powder, for solution - Intravenous, Powder, for solution - Intramuscular; Intravenous, Powder, Powder - Oral, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Granule, for suspension - Oral, Granule, for suspension

Septicemia

, 1500.0 mg, 750.0 mg, 7500.0 mg, 750.0 mg/mL, 90.0 mg/mL, 500.0 mg, 250.0 mg, 150.0 mg/mL, 7.5 mg/mL, 15.0 mg/mL, 250.0 mg/mL, 125.0 mg, 125.0 mg/mL, 75000.0 mg, 225000.0 mg, 95.0 mg/mL, 75.0 mg/mL

, Intravenous, Injection, powder, for solution - Intravenous, Injection, powder, for solution, Intramuscular; Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet - Oral, Tablet, Injection, solution, Injection, solution - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Suspension - Oral, Suspension, Powder, for solution, Powder, for solution - Oral, Powder, for solution - Intravenous, Powder, for solution - Intramuscular; Intravenous, Powder, Powder - Oral, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Granule, for suspension - Oral, Granule, for suspension

Operative Surgery

, 1500.0 mg, 750.0 mg, 7500.0 mg, 750.0 mg/mL, 90.0 mg/mL, 500.0 mg, 250.0 mg, 150.0 mg/mL, 7.5 mg/mL, 15.0 mg/mL, 250.0 mg/mL, 125.0 mg, 125.0 mg/mL, 75000.0 mg, 225000.0 mg, 95.0 mg/mL, 75.0 mg/mL

, Intravenous, Injection, powder, for solution - Intravenous, Injection, powder, for solution, Intramuscular; Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet - Oral, Tablet, Injection, solution, Injection, solution - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Suspension - Oral, Suspension, Powder, for solution, Powder, for solution - Oral, Powder, for solution - Intravenous, Powder, for solution - Intramuscular; Intravenous, Powder, Powder - Oral, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Granule, for suspension - Oral, Granule, for suspension

Bacterial Infections

, 1500.0 mg, 750.0 mg, 7500.0 mg, 750.0 mg/mL, 90.0 mg/mL, 500.0 mg, 250.0 mg, 150.0 mg/mL, 7.5 mg/mL, 15.0 mg/mL, 250.0 mg/mL, 125.0 mg, 125.0 mg/mL, 75000.0 mg, 225000.0 mg, 95.0 mg/mL, 75.0 mg/mL

, Intravenous, Injection, powder, for solution - Intravenous, Injection, powder, for solution, Intramuscular; Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet - Oral, Tablet, Injection, solution, Injection, solution - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Suspension - Oral, Suspension, Powder, for solution, Powder, for solution - Oral, Powder, for solution - Intravenous, Powder, for solution - Intramuscular; Intravenous, Powder, Powder - Oral, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Granule, for suspension - Oral, Granule, for suspension

Urinary Tract Infection (UTI)

, 1500.0 mg, 750.0 mg, 7500.0 mg, 750.0 mg/mL, 90.0 mg/mL, 500.0 mg, 250.0 mg, 150.0 mg/mL, 7.5 mg/mL, 15.0 mg/mL, 250.0 mg/mL, 125.0 mg, 125.0 mg/mL, 75000.0 mg, 225000.0 mg, 95.0 mg/mL, 75.0 mg/mL

, Intravenous, Injection, powder, for solution - Intravenous, Injection, powder, for solution, Intramuscular; Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet - Oral, Tablet, Injection, solution, Injection, solution - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Suspension - Oral, Suspension, Powder, for solution, Powder, for solution - Oral, Powder, for solution - Intravenous, Powder, for solution - Intramuscular; Intravenous, Powder, Powder - Oral, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Granule, for suspension - Oral, Granule, for suspension

Gonorrhea

, 1500.0 mg, 750.0 mg, 7500.0 mg, 750.0 mg/mL, 90.0 mg/mL, 500.0 mg, 250.0 mg, 150.0 mg/mL, 7.5 mg/mL, 15.0 mg/mL, 250.0 mg/mL, 125.0 mg, 125.0 mg/mL, 75000.0 mg, 225000.0 mg, 95.0 mg/mL, 75.0 mg/mL

, Intravenous, Injection, powder, for solution - Intravenous, Injection, powder, for solution, Intramuscular; Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet - Oral, Tablet, Injection, solution, Injection, solution - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Suspension - Oral, Suspension, Powder, for solution, Powder, for solution - Oral, Powder, for solution - Intravenous, Powder, for solution - Intramuscular; Intravenous, Powder, Powder - Oral, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Granule, for suspension - Oral, Granule, for suspension

Bone and Joint Infections

, 1500.0 mg, 750.0 mg, 7500.0 mg, 750.0 mg/mL, 90.0 mg/mL, 500.0 mg, 250.0 mg, 150.0 mg/mL, 7.5 mg/mL, 15.0 mg/mL, 250.0 mg/mL, 125.0 mg, 125.0 mg/mL, 75000.0 mg, 225000.0 mg, 95.0 mg/mL, 75.0 mg/mL

, Intravenous, Injection, powder, for solution - Intravenous, Injection, powder, for solution, Intramuscular; Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet - Oral, Tablet, Injection, solution, Injection, solution - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Suspension - Oral, Suspension, Powder, for solution, Powder, for solution - Oral, Powder, for solution - Intravenous, Powder, for solution - Intramuscular; Intravenous, Powder, Powder - Oral, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Granule, for suspension - Oral, Granule, for suspension

Maxillary Sinusitis

, 1500.0 mg, 750.0 mg, 7500.0 mg, 750.0 mg/mL, 90.0 mg/mL, 500.0 mg, 250.0 mg, 150.0 mg/mL, 7.5 mg/mL, 15.0 mg/mL, 250.0 mg/mL, 125.0 mg, 125.0 mg/mL, 75000.0 mg, 225000.0 mg, 95.0 mg/mL, 75.0 mg/mL

, Intravenous, Injection, powder, for solution - Intravenous, Injection, powder, for solution, Intramuscular; Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet - Oral, Tablet, Injection, solution, Injection, solution - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Suspension - Oral, Suspension, Powder, for solution, Powder, for solution - Oral, Powder, for solution - Intravenous, Powder, for solution - Intramuscular; Intravenous, Powder, Powder - Oral, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Granule, for suspension - Oral, Granule, for suspension

Acute Bacterial Exacerbation of Chronic Bronchitis (ABECB)

, 1500.0 mg, 750.0 mg, 7500.0 mg, 750.0 mg/mL, 90.0 mg/mL, 500.0 mg, 250.0 mg, 150.0 mg/mL, 7.5 mg/mL, 15.0 mg/mL, 250.0 mg/mL, 125.0 mg, 125.0 mg/mL, 75000.0 mg, 225000.0 mg, 95.0 mg/mL, 75.0 mg/mL

, Intravenous, Injection, powder, for solution - Intravenous, Injection, powder, for solution, Intramuscular; Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet - Oral, Tablet, Injection, solution, Injection, solution - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Suspension - Oral, Suspension, Powder, for solution, Powder, for solution - Oral, Powder, for solution - Intravenous, Powder, for solution - Intramuscular; Intravenous, Powder, Powder - Oral, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Granule, for suspension - Oral, Granule, for suspension

prophylaxis of infection in minor cuts, scrapes, or burns

, 1500.0 mg, 750.0 mg, 7500.0 mg, 750.0 mg/mL, 90.0 mg/mL, 500.0 mg, 250.0 mg, 150.0 mg/mL, 7.5 mg/mL, 15.0 mg/mL, 250.0 mg/mL, 125.0 mg, 125.0 mg/mL, 75000.0 mg, 225000.0 mg, 95.0 mg/mL, 75.0 mg/mL

, Intravenous, Injection, powder, for solution - Intravenous, Injection, powder, for solution, Intramuscular; Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet - Oral, Tablet, Injection, solution, Injection, solution - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Suspension - Oral, Suspension, Powder, for solution, Powder, for solution - Oral, Powder, for solution - Intravenous, Powder, for solution - Intramuscular; Intravenous, Powder, Powder - Oral, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Granule, for suspension - Oral, Granule, for suspension

Animal bite

, 1500.0 mg, 750.0 mg, 7500.0 mg, 750.0 mg/mL, 90.0 mg/mL, 500.0 mg, 250.0 mg, 150.0 mg/mL, 7.5 mg/mL, 15.0 mg/mL, 250.0 mg/mL, 125.0 mg, 125.0 mg/mL, 75000.0 mg, 225000.0 mg, 95.0 mg/mL, 75.0 mg/mL

, Intravenous, Injection, powder, for solution - Intravenous, Injection, powder, for solution, Intramuscular; Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet - Oral, Tablet, Injection, solution, Injection, solution - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Suspension - Oral, Suspension, Powder, for solution, Powder, for solution - Oral, Powder, for solution - Intravenous, Powder, for solution - Intramuscular; Intravenous, Powder, Powder - Oral, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Granule, for suspension - Oral, Granule, for suspension

Warnings

Cefuroxime Sodium has one contraindication, and it should not be administered if you are encountering any of the conditions in the following table.Cefuroxime Sodium Contraindications

Condition

Risk Level

Notes

Pulse Frequency

Do Not Combine

There are 20 known major drug interactions with Cefuroxime Sodium.

Common Cefuroxime Sodium Drug Interactions

Drug Name

Risk Level

Description

Neomycin

Major

The risk or severity of nephrotoxicity can be increased when Cefuroxime is combined with Neomycin.

Tenofovir

Major

Cefuroxime may increase the nephrotoxic activities of Tenofovir.

Tenofovir alafenamide

Major

Cefuroxime may increase the nephrotoxic activities of Tenofovir alafenamide.

Tenofovir disoproxil

Major

Cefuroxime may increase the nephrotoxic activities of Tenofovir disoproxil.

Vibrio cholerae CVD 103-HgR strain live antigen

Major

The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Cefuroxime.

Cefuroxime Sodium Toxicity & Overdose RiskAllergic reactions such as rashes, sneezing, throat dryness, eye irritation, or severe allergic shock may occur with cephalosporin overdose. It can also lead to brain irritation and seizures.

image of a doctor in a lab doing drug, clinical research

Cefuroxime Sodium Novel Uses: Which Conditions Have a Clinical Trial Featuring Cefuroxime Sodium?

146 active trials are currently assessing the utility of Cefuroxime Sodium for the management of moderate Streptococcal pharyngitis, Bacterial Infections and Animal bites.

Condition

Clinical Trials

Trial Phases

Operative Surgery

84 Actively Recruiting

Not Applicable, Phase 3, Phase 4, Phase 2, Phase 1

prophylaxis of infection in minor cuts, scrapes, or burns

0 Actively Recruiting

Bacterial Meningitis

2 Actively Recruiting

Phase 1, Phase 2

Tonsillitis

0 Actively Recruiting

Otitis Media

0 Actively Recruiting

Lower Respiratory Tract Infection (LRTI)

1 Actively Recruiting

Phase 3

moderate Streptococcal tonsillitis

0 Actively Recruiting

Urinary Tract Infection

8 Actively Recruiting

Not Applicable, Phase 4, Phase 3

Impetigo

0 Actively Recruiting

Maxillary Sinusitis

0 Actively Recruiting

Septicemia

1 Actively Recruiting

Not Applicable

Urinary Tract Infection (UTI)

24 Actively Recruiting

Phase 2, Phase 1, Phase 4, Phase 3, Not Applicable

Gonorrhea

1 Actively Recruiting

Not Applicable

mild Streptococcal pharyngitis

0 Actively Recruiting

Animal bite

0 Actively Recruiting

Acute Bacterial Exacerbation of Chronic Bronchitis (ABECB)

0 Actively Recruiting

Bacterial Infections

1 Actively Recruiting

Phase 4

moderate Streptococcal pharyngitis

0 Actively Recruiting

Bone and Joint Infections

0 Actively Recruiting

Lyme Disease

8 Actively Recruiting

Phase 3, Phase 2, Phase 1, Not Applicable

Cefuroxime Sodium Reviews: What are patients saying about Cefuroxime Sodium?

5Patient Review

7/25/2018

Cefuroxime Sodium for infection caused by bacteria

IV Cefuroxime was prescribed to me for tick borne infections and it worked very well. I did experience some soreness in my throat and swollen glands, but that was from the bacteria dying off. Otherwise, no negative side effects.

image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about cefuroxime sodium

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is cefuroxime sodium used for?

"Cefuroxime is used to injected to treat various infections, examples include pneumonia, meningitis, gonorrhea, and skin, blood, bone, joint, and urinary infections caused by bacteria."

Answered by AI

Is cefuroxime a strong antibiotic?

"Do cefuroxime and amoxicillin work for the same infections? Both drugs are commonly used to treat similar types of infections; however, there are some types of infection where one may be better."

Answered by AI

Does cefuroxime contain sodium?

"This is equivalent to 4% of the recommended maximum daily dietary intake of sodium for an adult.

Each vial of Cefuroxime Injection 750mg contains 40.6mg of sodium, which is equivalent to 2% of the recommended maximum daily dietary intake of sodium for an adult. Each vial of Cefuroxime Injection 1.5g contains 81.3mg of sodium, which is equivalent to 4% of the recommended maximum daily dietary intake of sodium for an adult."

Answered by AI

What drug class is cefuroxime sodium?

"Cefuroxime belongs to a class of antibiotics called cephalosporins. These drugs work by preventing the growth of bacteria."

Answered by AI

Clinical Trials for Cefuroxime Sodium

Image of Hospital of the University of Pennsylvania in Philadelphia, United States.

Neuralert Monitoring System for Surgery

Philadelphia, PA

This trial will test a new monitoring system called Neuralert to see if it can detect strokes earlier than current methods. Patients will wear the device on both arms for up to five days. The trial will

Waitlist Available

Hospital of the University of PennsylvaniaNeuralert Technologies LLC

Image of Victoria General Hospital in Halifax, Canada.

Prehabilitation for Tumors

Halifax, Canada

This trial aims to help lung and esophageal cancer patients improve their health before surgery by offering an 8-week coaching program focused on nutrition, quitting smoking, better sleep, and exercise. Studies show

Waitlist Available

Victoria General Hospital

Image of University of Colorado Hospital in Aurora, United States.

Non-pulsatile blood flow +1 More for Low Platelet Count

This trial aims to see if using a specific type of blood flow during heart surgery can help reduce the risk of kidney damage. Researchers will also look at how safe and effective this method is compared to the

Waitlist Available

University of Colorado HospitalNathan J Clendenen, MD, MS

Image of Massachusetts General Hospital in Boston, United States.

Fecal ostomy surgery participants receiving the CI-oSurg for Surgery

This trial will test a new communication program for people undergoing fecal ostomy surgery. They will include 24 patients and 4 clinicians to see if the program is helpful. They will focus on patients

Massachusetts General Hospital

Have you considered Cefuroxime Sodium clinical trials? We made a collection of clinical trials featuring Cefuroxime Sodium, we think they might fit your search criteria.

Explore trials for Cefuroxime Sodium

Image of Cleveland Clinic Foundation in Cleveland, United States.

Personalized outcome prediction tool + targeted interventions for Knee Arthritis

This trial will test if using a personalized tool to predict outcomes for knee replacement surgery, along with specific interventions for patients with mental health and physical function issues, can improve patient satisfaction after one year compared to

Cleveland Clinic FoundationNicolas S Piuzzi, MD

Image of University of Alberta Hospital in Edmonton, Canada.

Regional Anesthesia for Hip Fracture

Edmonton, Canada

This trial aims to compare two commonly used anesthesia techniques for hip fracture surgery in adults. The study will look at how each technique affects the patients' pain levels and the amount of pain medication needed after surgery

Waitlist Available

University of Alberta Hospital

Image of Walter Reed National Military Medical Center in Bethesda, United States.

BioEnthesis Augmentation for Rotator Cuff Tears

This trial aims to improve the success rate of rotator cuff repairs. The current method involves using suture anchor-based techniques, but this often leads to re-tearing of the connective tissue. A

Walter Reed National Military Medical Center (+1 Sites)Jonathan Dickens, MD

Image of Nationwide Children's Hospital in Columbus, United States.

Regional Anesthesia EMG Study for Surgery

No minimum age - 5

This trial will use a non-invasive monitoring technique called EMG to study how spinal and caudal anesthesia works in children during surgery. They will also look at how adding clonidine affects the

Nationwide Children's HospitalGrant Heydinger, MD

Have you considered Cefuroxime Sodium clinical trials? We made a collection of clinical trials featuring Cefuroxime Sodium, we think they might fit your search criteria.

Explore trials for Cefuroxime Sodium

Image of Houston Methodist Research Institute in Houston, United States.

Virtual Reality Software for Delirium

This trial will test if using virtual reality software called ReCognitionVR is possible, liked by patients, and safe for older people who have had surgery. The results will help plan a future study for

Waitlist Available

Houston Methodist Research InstituteHina Faisal, MD

Image of University of Wisconsin Hospitals and Clinics (UWHC) in Madison, United States.

Laparotomy plus Local Wound Anesthetic for Pain relief

This trial is being conducted to determine if a pain control method called preoperative transversus abdominis plane (TAP) analgesia is as effective as surgeon-initiated wound infiltration with local anesthesia

University of Wisconsin Hospitals and Clinics (UWHC)Sumer Wallace, MD

Image of Rocky Mountain Regional VAMC in Aurora, United States.

Telehealth follow-up for Surgery

This trial aims to evaluate the use of telehealth (phone or video) for follow-up care after surgery in rural and urban Veterans. Currently, telehealth is not widely used in surgical care, but

Waitlist Available

Rocky Mountain Regional VAMC (+3 Sites)

Image of Cleveland Clinic Foundation in Cleveland, United States.

Oral care treatment as usual for Oral Bacterial Infection

This trial is going to compare the effectiveness of two different oral care treatments in patients who have a tube in their throat. The goal of the trial is to see which treatment can reduce the amount of bacteria

Waitlist Available

Cleveland Clinic FoundationMarcelo Gama de Abreu, MD

Have you considered Cefuroxime Sodium clinical trials? We made a collection of clinical trials featuring Cefuroxime Sodium, we think they might fit your search criteria.

Explore trials for Cefuroxime Sodium

Unbiased ResultsWe believe in providing patients with all the options.

Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.

Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.

Back to top

Terms of Service Privacy Policy Security